






© The American Society for Clinical Investigation, Inc.
0021-9738/97/10/1928/06 $2.00











 Have a Synergistic Role in Rescuing Epithelial Barrier 
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Prostaglandins (PG) are cytoprotective for gastrointestinal
epithelium, possibly because they enhance mucosal repair.
The objective of the present studies was to assess the role of
prostaglandins in intestinal repair. Intestinal mucosa from
porcine ileum subjected to 1 h of ischemia was mounted in
Ussing chambers. Recovery of normal transepithelial elec-
trical resistance occurred within 2 h, and continued to in-
crease for a further 2 h to a value twice that of control. The
latter response was blocked by inhibition of prostaglandin










, whereas the addition of each
alone had little effect. Histologically, prostaglandins had no
effect on epithelial restitution or villous contraction, indi-
cating that elevations in transepithelial resistance were as-
sociated with increases in paracellular resistance. Further-
more, prostaglandin-stimulated elevations in resistance were
inhibited with cytochalasin D, an agent known to stimulate
cytoskeletal contraction. Synergistic elevations in transepi-





were also noted after treatment with cAMP and A23187 (a









a synergistic role in restoration of intestinal barrier function
 










































 in gastric epithelium by Robert et al., there has
been a great deal of research on the mechanism whereby pros-
taglandins protect tissues from various chemical and physical
insults (1–4). Prostaglandins have also proven to be important
in the small intestine, since chronic treatment of human pa-
tients with nonsteroidal antiinflammatory agents results in in-
creased small intestinal permeability (5). Theories to explain
cytoprotection, such as increased blood flow, have not gained
universal acceptance (2). It is possible that the cytoprotective
effects of prostaglandins are actually due to enhanced tissue
repair, rather than prevention of injury (4). Recent studies
have shown that stimulation of epithelial migration (restitu-
tion) by growth factors is mediated by prostaglandins, since in-
hibition of cyclooxygenase prevented growth factor–stimu-
lated restitution, and replacement of prostaglandins restored
the migratory process (6). In addition, prostaglandins have
been shown to stimulate villous contraction in the small intes-
tine (7), which aids restitution by decreasing villous surface
area (8). An effect of prostaglandins on epithelial tight junc-
tions has also been considered, but has received little attention
(3). Considering tight junctions control the passage of solutes
via the paracellular space, the major route of transepithelial
solute passage, physiologic control over tight junctions is of
major physiologic importance (9). Although once thought to
be inert connections, it has recently been determined that tight
junctions are dynamic structures that are regulated by media-
 










 (10–12). Since the








 in the intestinal tract are






, we postulated an important role
for these prostaglandins in regulation of paracellular perme-




Six- to eight-week-old Yorkshire crossbred pigs of either sex were
anesthetized, and the ileum was approached via a ventral midline in-
cision. Porcine ileal segments were delineated by ligating the intesti-
nal lumen at 10-cm intervals, and subjected to ischemia by clamping
the local mesenteric blood supply. After the desired period of isch-















 aperture Ussing chambers, as described in previous studies (13).
Tissues were bathed on the serosal and mucosal sides with 10 ml
Ringer’s solution. The serosal bathing solution contained 10 mM glu-
cose, and was osmotically balanced on the mucosal side with 10 mM









circulated in water-jacketed reservoirs. The spontaneous potential
difference (PD) was measured using Ringer-agar bridges connected
to calomel electrodes, and the PD was short-circuited through Ag–










) was calculated from the spontaneous PD
















A for 5 s
and the PD recorded. Short-circuit current and PD were recorded ev-
ery 15 min for 4 h. Treatments were added to serosal or mucosal
bathing solutions as appropriate before mounting tissues on Ussing
chambers. Select tissues were removed at 1-h intervals and at the end









m intervals, and stained with hematoxylin and eosin).
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, mucosal-to-serosal flux; PG, prostaglandin.
 
 

























Ci/ml) to the serosal bathing solu-
tions once tissues were mounted in Ussing chambers. Time zero sam-
ples were taken from the reservoirs after a 15-min equilibration
period. After a further 15-min equilibration period, the first flux was
initiated over the following 60 min, and performed at 60-min intervals





 emission (counts/minute). The windows on the scintillation counter



















 in response to prostaglandins
was assessed in a porcine jejunal enterocyte line (IPEC-J2) because
of the inability to accurately measure the concentration and cellular
location of second messengers in native mucosal tissues. We have
previously reported on methods used to study this cell line (14). Cells












 air humidified incubator in
Dulbeccos’s modified Eagle’s medium with 5% calf serum, 0.1% pen-




-glutamine, and 0.1% of a
mixture of 50 mg/liter insulin, 250 mg/liter transferrin, and 250 mg/li-
ter Se. Cells were studied at passage 62, and grown to 100% conflu-
ence. Measurements of cAMP were obtained in cells pretreated for 5
























or both for 15 min, after which cells were washed twice with PBS, and
immersed in 6% perchloric acid. After centrifugation and repeated
washing, ether extraction was performed three times. Cyclic AMP












were obtained using a modular fluorim-
eter system attached to an inverted microscope as previously de-
scribed (15). IPEC-J2 cells were loaded with fura-2, which was added















Cells were washed with NaCl Ringers and mounted in a chamber
over the objective of the microscope. Fluorescence from cells was ac-
quired alternately at 340 and 380 nm with a photometer and passed to
a photomultiplier. A microcomputer averaged the emission intensi-
ties collected over 1-s time intervals from each of the excitation wave-















Tissues subjected to 30, 45, 60, and 120 min of ischemia recov-
ered control levels of resistance when mounted in Ussing
chambers according to the severity of mucosal injury: 2-h isch-
emic tissues required 4 h to recover normal resistance, whereas
tissues exposed to 30–60 min recovered normal resistance
more rapidly, followed by an elevation in resistance. The ele-
vation in resistance was most apparent in 1-h ischemic tissues,










 M indomethacin to the







 M carbacyclin to indomethacin-treated ischemic tissues
had no effect on transepithelial resistance (i.e., similar to isch-
















 had a striking synergistic effect on resis-
tance (Fig. 2), which not only reversed the indomethacin ef-
fect, but within 2 h increased resistance to maximal levels seen
in untreated ischemic tissues.
Histopathologic examination of mucosa immediately after





5.6% of the villous perimeter was denuded). After
4 h in the Ussing chamber, villi were covered by flattened epi-
thelium as a result of restitution (migration of epithelium
across denuded villous tips). In addition, these latter tissues
demonstrated marked reductions in villous height compared
 
with control tissues maintained in Ussing chambers for the

























 6). Reductions in villous height were apparently not
due to neurally mediated villous contraction, since addition of






 M) to the serosal surface
of tissues had no effect on villous height. Injured tissues
treated with indomethacin had similar histologic evidence of
















 6) and had




































labeled inulin were performed to further investigate changes in
electrical resistance. Inulin, which is a polysaccharide of con-
siderable size (11.5 Å stokes radius), traverses leaky epithelia




 9 Å stokes radius) (9, 11). Inulin
fluxes in injured tissues paralleled changes in resistance. In
particular, indomethacin exacerbated elevations in inulin flux





 significantly reduced inulin flux (Fig. 3). Flux of the
smaller mannitol (4 Å stokes radius) showed similar trends,
except that mannitol fluxes did not return to control levels in








































Considering the remarkable differences between treat-
ments in resistance and mucosal-to-serosal flux of inulin at 60
min (Figs. 2 and 3), tissues were removed after 1 h in the
Figure 1. Electrical responses of repairing tissues. Tissues subjected 
to 1 h of ischemia had markedly reduced resistances at the beginning 
of the experiment. Control levels of resistance were attained in these 
tissues after 120 min, after which resistance continued to climb until it 
was approximately twofold that of control tissue. Addition of in-
domethacin to mucosal and serosal bathing solutions of injured tis-
sues resulted in slower recovery of resistance, such that resistance 
only attained control levels of resistance at 240 min. Data points rep-






Ussing chamber for histologic examination. Restitution was













0.7% of the villous perime-
ter was denuded in ischemic, indomethacin-treated ischemic,









 4). Measurements of villous height at 1 h were
similar to those taken at 4 h. Taken together, these findings
suggested an increase in paracellular resistance as the cause of
higher levels of transepithelial resistance in prostaglandin-
treated tissues, rather than mechanisms involving villous con-
traction or epithelial restitution.
Increases in paracellular resistance have been associated
with mucosal exposure to osmotic loads (16). Physiologically,
increases in mucosal osmotic loads may occur during chloride









 (17). In support of this concept, addition of prostaglandins
to injured tissues in the present study resulted in additive but



















 to indomethacin-treated in-



















respectively, n 5 6), suggesting that prostaglandin-induced in-
creases in paracellular resistance may be associated with chlo-
ride secretion.
We speculated that tight junctions responded to cAMP
(10), triggered by PGE2 receptor-mediated adenylate cyclase
activity (17) and release of intracellular calcium (12) triggered
by PGI2-stimulated cholinergic nerves (18). To test this hy-
pothesis, 1025 M 8-bromo-cAMP and 1027 M A23187 (a potent
and specific Ca21 ionophore) were added to the serosal or mu-
cosal and serosal bathing solutions of indomethacin-treated
tissues, respectively. Similar synergistic elevations in transepi-
thelial resistance between cAMP and Ca21 were noted in in-
jured tissues during the first 60 min of the experiment (Fig. 4).
In further experiments, IPEC-J2 cells were exposed to carba-
cyclin (1026 M), PGE2 (1026 M), or both to isolate the effects
of prostaglandins on intestinal epithelial second messengers.
Prostaglandin E2 triggered a significant increase in cAMP
compared with control (18.861.4 and 9.761.2 pmol/ml, respec-
tively, n 5 3, P , 0.05 [one-way ANOVA]), but the addition
of carbacyclin had no further effect (18.963.6 pmol/ml), and
carbacylcin alone had no effect (14.561.4 pmol/ml; P . 0.05
versus control).
There was no effect of either prostaglandin on [Ca21]i in
IPEC-J2 cells, while 1024 M ATP induced marked elevations
in [Ca21]i (data not shown). We postulated that the inability of
prostaglandins to stimulate elevations in [Ca21]i resulted from
the absence of enteric nerves in cell culture, since carbacyclin
has been shown to act via cholinergic and VIPergic nerves in
porcine intestine (19). Therefore, we applied 1027 M tetrodo-
toxin to the serosal surface of indomethacin-treated ischemicFigure 2. Response of repairing tissues to prostaglandins. The effects 
of indomethacin on tissues subjected to 1 h of ischemia were reversed 
by addition of both carbacyclin and PGE2. Carbacyclin alone had no 
discernible effect, whereas PGE2 had a limited effect. Treatment with 
carbacyclin and PGE2 resulted in significantly greater elevations in 
resistance than the additive effects of the individual prostaglandins 
indicating a synergistic relationship between carbacyclin and PGE2. 
Statistical significance was determined by two-way analysis of vari-
ance for repeated measures (SigmaStat, version 2.0; Jandel Scientific, 
San Rafael, CA). Data points represent the mean6SE, n 5 6.
Figure 3. Mucosal-to-serosal flux of inulin across injured tissues. Isch-
emic tissues recovered normal mucosal-to-serosal flux of 14C-inulin 
steadily over 240 min. Treatment with indomethacin significantly in-
creased the flux of inulin during the initial flux periods, and addition 
of carbacyclin and PGE2 resulted in significant decreases in 14C-inulin 
flux compared with ischemic tissues in the presence of indomethacin 
alone. Statistical significance was determined by two-way analysis of 
variance for repeated measures. Data points represent the mean6SE, 
n 5 5.
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tissues 30 min before the addition of prostaglandins, and inhib-
ited recovery of transepithelial resistance to the level attained
with PGE2 treatment alone (Fig. 5). Furthermore, 1025 M sero-
sal atropine had a similar effect as tetrodotoxin, whereas sero-
sal application of 1026 M of the VIP receptor antagonist [Lys1,
Pro2,5, Arg3,4, Tyr6]-VIP had no effect. Taken together, these
experiments suggest that prostaglandins, most likely carbacy-
clin, act via cholinergic nerves which would be expected to
trigger increases in [Ca21]i.
To assess the role of the tight junction-cytoskeletal inter-
face in prostaglandin-stimulated increases in resistance, 1026
M cytochalasin D, an agent known to stimulate cytoskeletal
contraction and opening of tight junctions (20), was added to
ischemic tissues treated with indomethacin and prostaglandins.
Cytochalasin D abolished previously noted synergistic eleva-
tions in transepithelial resistance in response to prostaglandins
(Fig. 6). However, cytochalasin D did not lower the resistance
of control tissues, suggesting that inhibition of recovery of
transepithelial resistance in injured tissues was not a result of a
nonspecific toxic effect. In addition, we evaluated cytochalasin
D–treated tissues for evidence of reduced epithelial restitu-
tion, since restitution also depends on a functional cytoskele-
ton and may be inhibited by cytochalasin D (21). However,
ischemic tissues treated with indomethacin and prostaglandins
appeared to restitute similarly in the presence of cytochalasin
Figure 4. Response of repairing tissues to A23187 and cAMP. Addi-
tion of the calcium ionophore A23187 and cAMP to indomethacin-
treated ischemic tissues partially duplicated the results of addition of 
carbacyclin and PGE2 to similarly treated tissues, suggesting the pos-
sibility that the effect of the prostaglandins was mediated through 
their respective second messengers. Addition of A23187 had no effect 
on its own (no increase above baseline measurements), whereas 
cAMP caused marked increases in tissue resistance. Between 45 and 
90 min after addition of both A23187 and cAMP, there was a signifi-
cant synergistic increase in resistance. Statistical significance was de-
termined by two-way analysis of variance. Data points represent the 
mean6SE, n 5 6. *P , 0.05 for A23187/cAMP/indomethacin-treated 
tissues versus the additive effect of A23187/indomethacin and cAMP/
indomethacin-treated tissues.
Figure 5. Response of injured tissues to prostaglandins after pretreat-
ment with the neural-inhibitory agents tetrodotoxin, atropine and the 
VIP antagonist LPAT. Tetrodotoxin and atropine inhibit recovery of 
resistance at 120 min to levels similar to those of tissues treated with 
PGE2 alone, whereas the VIP antagonist had no effect. Statistical sig-
nificance was determined by two-way analysis of variance. Bars rep-
resent the mean6SE, n 5 6. *P , 0.05 versus tissues treated with 
PGE2 and carbacyclin (PGs).
Figure 6. Response of indomethacin/ prostaglandin-treated tissues to 
the actin-binding agent cytochalasin D. Cytochalasin D abolishes 
prostaglandin-mediated recovery of transepithelial resistance. Data 
points represent the mean6SE, n 5 4.
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D (3.461.4% of the villous perimeter was denuded in prosta-
glandin/indomethacin-treated ischemic tissues in the presence
of cytochalasin D at 60 min, n 5 4).
Discussion
These findings have important implications for damaged or
leaky epithelia. Prostaglandins have often been assumed to
have detrimental effects on tissues as mediators of inflamma-
tion (22). In contrast, the present findings suggest that prosta-
glandins play a salutary role in early restoration of epithelial
barrier function. Although repair mechanisms attributed to
prostaglandins have previously included enhanced epithelial
restitution (6), and subepithelial myofibroblast contraction (7),
increased resistance of tight junctions appears to provide an
equally important method of rescuing barrier function. The
mechanism by which prostaglandins regulate paracellular per-
meability is unknown, but may include alteration of tight junc-
tion structure or functional regulation via second messengers.
Since PGI2 and PGE2 reportedly stimulate increases in in-
tracellular Ca21 and cAMP (18), we considered the possibility
that prostaglandins regulate tight junctions via second messen-
gers. Synergistic increases in resistance with application of a
calcium ionophore and cAMP were consistent with this hy-
pothesis. In addition, PGE2 directly stimulated increases in
cAMP in porcine epithelial cells. While neither PGE2 nor car-
bacyclin stimulated increases in [Ca21]i in isolated epithelial
cells, the cholinergic nerve inhibitor atropine prevented syner-
gism between PGE2 and carbacyclin, suggesting that PGI2
stimulates cholinergic nerves to trigger elevations in [Ca21]i.
Differences in magnitude of response between the prostaglan-
dins and A23187 and cAMP were attributed to supraphysio-
logic concentrations of cAMP and Ca21 that may result from
treatment of tissues with a Ca21 ionophore (9) and the cell sol-
uble 8-bromo-cAMP.
Previous studies have shown that application of A23187
and cAMP to Necturus gallbladder increase transepithelial re-
sistance associated with an increase in the numbers of tight
junction filaments (10, 12). However, it is difficult to envision
how tight junction strands could accumulate so rapidly. More
recent studies suggest that the key site of tight junction regula-
tion is the cytoskeleton-tight junction interface (20, 23–25).
The cytoskeleton regulates tight junction resistance by actin fi-
ber contraction (which opens tight junctions) or relaxation
(which passively allows tight junctions to close) (20). Our ex-
periments tend to support the hypothesis that prostaglandins,
via the second messengers Ca21 and cAMP, trigger closure of
tight junctions via the cytoskeleton, since the actin-binding
agent cytochalasin D inhibited prostaglandin-stimulated re-
covery of injured tissues. Previous studies have shown that ap-
plication of cytochalasin D to epithelial monolayers reduces
transepithelial resistance and increases transepithelial manni-
tol and inulin fluxes without disrupting epithelial monolayers
(20). Alterations in transepithelial resistance were attributed
to changes in tight junction permeability because of a strong
correlation between Na1 and mannitol fluxes. Our studies
were complicated by the nature of the tissue (stripped tissue
with secondary villous structure) and the presence of an epi-
thelial defect requiring coverage by epithelial restitution.
However, based on histologic evidence of near-maximal vil-
lous contraction and epithelial restitution at 60 min regardless
of treatment, we believe that the present studies suggest that
prostaglandins induce closure of tight junctions as a mecha-
nism of rescuing epithelial barrier function.
Acknowledgments
We thank Dr. Anthony M. Paradiso, Department of Medicine, Uni-
versity of North Carolina at Chapel Hill for performing measure-
ments of [Ca21]i.
The senior author is supported by a National Research Scholar-
ship Award from the National Institutes of Health (F32 DK09400-
01). This work was supported by a grant from the Center for the
study of Gastrointestinal Biology and Disease, North Carolina State
University & University of North Carolina at Chapel Hill (UNC
#5-32583).
References
1. Robert, A. 1979. Cytoprotection by prostaglandins. Gastroenterology. 77:
761–767.
2. Jacobson, E.D. 1992. Circulatory mechanisms of gastric mucosal damage
and protection. Gastroenterology. 102:1788–1800.
3. Miller, T.A. 1983. Protective effects of prostaglandins against gastric mu-
cosal damage; current knowledge and proposed mechanisms. Am. J. Physiol. 8:
G601–G623.
4. Hawkey, C.J., and D.S. Rampton. 1985. Prostaglandins and the gas-
trointestinal tract: are they important in its function, disease, or treatment?
Gastroenterology. 89:1162–1188.
5. Gyires, K. 1994. Some of the factors that may mediate or modify the gas-
trointestinal mucosal damage induced by non-steroidal anti-inflammatory
drugs. Agents Actions. 41:73–79.
6. Zushi, S., Y. Shinomura, T. Kiyohara, T. Minami, M. Sugimachi, Y. Hi-
gashimoto, S. Kanayama, and Y. Matsuzawa. 1996. The role of prostaglandins
in intestinal epithelial restitution stimulated by growth factors. Am. J. Physiol.
270:G757–G762.
7. Erickson, R.A., A. Tarnawski, G. Dines, and J. Stachura. 1990. 16,16-
dimethyl prostaglandin E2 induces villous contraction in rats without affecting
intestinal restitution. Gastroenterology. 99:708–716.
8. Moore, R., S. Carlson, and J.L. Madara. 1989. Villous contraction aids re-
pair of intestinal epithelium after injury. Am. J. Physiol. 257:G274–G283.
9. Madara, J.L. 1989. Loosening tight junctions: Lessons from the intestine.
J. Clin. Invest. 83:1089–1094.
10. Duffey, M.E., B. Hainau, and C.J. Bentzel. 1981. Regulation of epithe-
lial tight junction permeability by cyclic AMP. Nature (Lond.). 294:451–453.
11. Madara, J.L., and J. Stafford. 1989. Interferon-g directly affects barrier
function of cultured human epithelial monolayers. J. Clin. Invest. 83:724–727.
12. Palant, C.E., M.E. Duffey, B.K. Mookerjee, and C.J. Bentzel. 1983.
Ca21 regulation of tight-junction permeability and structure in Necturus gall-
bladder. Am. J. Physiol. 245:C203–C212.
13. Argenzio, R.A., J. Lecce, and D.W. Powell. 1993. Prostanoids inhibit
NaCl absorption in experimental porcine cryptosporidiosis. Gastroenterology.
104:440–447.
14. Rhoads, J.M., W. Chen, P. Chu, H.M. Berschneider, R.A. Argenzio, and
A.M. Paradiso. 1994. L-Glutamine and L-asparagine stimulate Na1/H1 ex-
change in porcine jejunal enterocytes. Am. J. Physiol. 266:G828–G838.
15. Paradiso, A.M., E.H.C. Cheng, and R.C. Boucher. 1991. Effects of
bradykinin on intracellular calcium regulation in human ciliated epithelium.
Am. J. Physiol. 261:L63–L69.
16. Smulders, A.P., J.M. Tormey, and E.M. Wright. 1972. Effect of osmoti-
cally induced water flows on the permeability and ultrastructure of the rabbit
gallbladder. J. Membr. Biol. 7:164–197.
17. Eberhart, C.E., and R.N. Dubois. 1995. Eicosanoids and the gastrointes-
tinal tract. Gastroenterology. 109:285–301.
18. Dimarzo, V.D. 1995. Arachidonic acid and eicosanoids as targets and ef-
fectors in second messenger interactions. Prostaglandins Leukot. Essent. Fatty
Acids. 53:239–254.
19. Argenzio, R.A., M. Armstrong, and J.M. Rhoads. 1996. Role of the en-
teric nervous system in piglet cryptosporidiosis. J. Pharmacol. Exp. Ther. 279:
1109–1115.
20. Madara, J.L., R. Moore, and S. Carlson. 1987. Alteration of intestinal
tight junction structure and permeability by cytoskeletal contraction. Am. J.
Physiol. 22:C854–C861.
21. McCormack, S.A., M.J. Viar, and L.R. Johnson. 1992. Migration of
IEC-6 cells: a model for mucosal healing. Am. J. Physiol. 263:G426–G435.
22. Lauritsen, K., L.S. Laursen, K. Bukhave, and J. Rask-Madsen. 1988. Ef-
Prostaglandins Rescue Barrier Function 1933
fects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and
leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in re-
lapsing ulcerative colitis. Gastroenterology. 95:11–17.
23. Madara, J.L. 1987. Increases in guinea pig small intestinal transepithe-
lial resistance induced by osmotic loads are accompanied by rapid alterations in
absorptive-cell tight-junction structure. J. Cell Biol. 97:125–136.
24. Anderson, J.M., and C.M. Van Italie. 1995. Tight junctions and the mo-
lecular basis for regulation of paracellular permeability. Am. J. Physiol. 32:
G467–G475.
25. Shasby, D.E., J.M. Kamath, A.B. Moy, and S.S. Shasby. 1995. Ionomy-
cin and PDBU increase MDCK monolayer permeability independently of myo-
sin light chain phosphorylation. Am. J. Physiol. 269:L144–L150.
